Active Biotech (Sweden) Market Value

ACTI Stock  SEK 0.12  0.01  9.09%   
Active Biotech's market value is the price at which a share of Active Biotech trades on a public exchange. It measures the collective expectations of Active Biotech AB investors about its performance. Active Biotech is selling for under 0.12 as of the 12th of December 2024; that is 9.09 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.12.
With this module, you can estimate the performance of a buy and hold strategy of Active Biotech AB and determine expected loss or profit from investing in Active Biotech over a given investment horizon. Check out Active Biotech Correlation, Active Biotech Volatility and Active Biotech Alpha and Beta module to complement your research on Active Biotech.
Symbol

Please note, there is a significant difference between Active Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Active Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Active Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Active Biotech 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Active Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Active Biotech.
0.00
12/23/2022
No Change 0.00  0.0 
In 1 year 11 months and 22 days
12/12/2024
0.00
If you would invest  0.00  in Active Biotech on December 23, 2022 and sell it all today you would earn a total of 0.00 from holding Active Biotech AB or generate 0.0% return on investment in Active Biotech over 720 days. Active Biotech is related to or competes with BioInvent International, Orexo AB, Alligator Bioscience, Swedish Orphan, and Anoto Group. Active Biotech AB , a biotechnology company, develops drugs for the treatment of neurodegenerative diseases, autoimmunit... More

Active Biotech Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Active Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Active Biotech AB upside and downside potential and time the market with a certain degree of confidence.

Active Biotech Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Active Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Active Biotech's standard deviation. In reality, there are many statistical measures that can use Active Biotech historical prices to predict the future Active Biotech's volatility.
Hype
Prediction
LowEstimatedHigh
0.010.1127.58
Details
Intrinsic
Valuation
LowRealHigh
0.010.1127.58
Details
Naive
Forecast
LowNextHigh
0.00070.0327.50
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.070.200.33
Details

Active Biotech AB Backtested Returns

Active Biotech appears to be out of control, given 3 months investment horizon. Active Biotech AB secures Sharpe Ratio (or Efficiency) of 0.0218, which signifies that the company had a 0.0218% return per unit of risk over the last 3 months. By analyzing Active Biotech's technical indicators, you can evaluate if the expected return of 0.6% is justified by implied risk. Please makes use of Active Biotech's Downside Deviation of 15.71, risk adjusted performance of 0.0163, and Mean Deviation of 11.1 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Active Biotech holds a performance score of 1. The firm shows a Beta (market volatility) of -1.3, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Active Biotech are expected to decrease by larger amounts. On the other hand, during market turmoil, Active Biotech is expected to outperform it. Please check Active Biotech's total risk alpha, treynor ratio, value at risk, as well as the relationship between the sortino ratio and maximum drawdown , to make a quick decision on whether Active Biotech's price patterns will revert.

Auto-correlation

    
  0.74  

Good predictability

Active Biotech AB has good predictability. Overlapping area represents the amount of predictability between Active Biotech time series from 23rd of December 2022 to 18th of December 2023 and 18th of December 2023 to 12th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Active Biotech AB price movement. The serial correlation of 0.74 indicates that around 74.0% of current Active Biotech price fluctuation can be explain by its past prices.
Correlation Coefficient0.74
Spearman Rank Test0.67
Residual Average0.0
Price Variance0.03

Active Biotech AB lagged returns against current returns

Autocorrelation, which is Active Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Active Biotech's stock expected returns. We can calculate the autocorrelation of Active Biotech returns to help us make a trade decision. For example, suppose you find that Active Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Active Biotech regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Active Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Active Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Active Biotech stock over time.
   Current vs Lagged Prices   
       Timeline  

Active Biotech Lagged Returns

When evaluating Active Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Active Biotech stock have on its future price. Active Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Active Biotech autocorrelation shows the relationship between Active Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in Active Biotech AB.
   Regressed Prices   
       Timeline  

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Active Stock Analysis

When running Active Biotech's price analysis, check to measure Active Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Active Biotech is operating at the current time. Most of Active Biotech's value examination focuses on studying past and present price action to predict the probability of Active Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Active Biotech's price. Additionally, you may evaluate how the addition of Active Biotech to your portfolios can decrease your overall portfolio volatility.